tradingkey.logo
搜索

Cardio Diagnostics Holdings Inc

CDIO
添加自选
1.550USD
-0.050-3.13%
收盘 07-24 16:00美东报价延迟15分钟
4.59M总市值
0.06市盈率 TTM

Cardio Diagnostics Holdings Inc

1.550
-0.050-3.13%

关于 Cardio Diagnostics Holdings Inc 公司

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Cardio Diagnostics Holdings Inc简介

公司代码CDIO
公司名称Cardio Diagnostics Holdings Inc
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)
员工数量13
证券类型Ordinary Share
年结日Nov 23
公司地址311 W. Superior Street
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编60645
电话18552269991
网址
公司代码CDIO
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)

Cardio Diagnostics Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
107.26K
+96.01%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
107.26K
+96.01%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--

常见问题

Cardio Diagnostics Holdings Inc的前五大股东是谁?

Cardio Diagnostics Holdings Inc 的前五大股东如下:Mr. Timur Dogan, Ph.D.

有多少机构持有Cardio Diagnostics Holdings Inc(CDIO)的股份?

截至2026Q1,共有38家机构持有Cardio Diagnostics Holdings Inc的股份,合计持有的股份价值约为138.49K,占公司总股份的4.68%。与2025Q4相比,机构持股有所增加,增幅为-23968.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有